InsidersTradesSigma
Track the UCB stock price and the full directors' dealings record of the company, a publicly traded company based in Belgium. Shares are quoted on the BE market, under the supervision of FSMA. Operating in the Healthcare & Pharma sector, UCB has logged 56 public disclosures. Market capitalisation: €42.5bn. The latest transaction was filed on 7 August 2026 (Purchase). Among the most active insiders: Caeymaex Emmanuel. The full history is accessible without an account.
56
Insider Decl.
n/a
Thresholds
€5m
41 ops.
Buy Volume
€18m
14 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate UCB Buy (bullish), based on 19 analysts. Average price target: €286.11.
32Σ signal
Fundamental score
Ranked 6,162 of 28,836 companies
66.0
score / 100
Value50
Quality82
FCF yld4.4%
Earn yld3.7%
EV/EBITDA17.3x
ROE21%
Gross mgn74%
Net mgn20%
Debt/EBITDA0.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 August 2026
Declarations56 total
350 shares@ €224.04ShareEuronext BrusselsISIN BE0003739530FSMA:ucb-201
315 shares@ €254.800.0002% mcap100.0% of flowShareEuronext BrusselsISIN BE0003739530FSMA:ucb-214
3,084 shares@ €270.890.0019% mcap22.3% of flowShareEuronext BrusselsISIN BE0003739530FSMA:ucb-126
7,937 shares@ €266.700.0047% mcap29.4% of flowShareEuronext BrusselsISIN BE0003739530FSMA:ucb-33
7,937 shares@ €102.040.0018% mcap11.2% of flowShareOff exchangeISIN BE0003739530FSMA:ucb-86
1,010 shares@ €271.800.0006% mcap3.8% of flowShareEuronext BrusselsISIN BE0003739530FSMA:ucb-62
4,031 shares0Options /warrants for employees or managersOff exchangeFSMA:ucb-129
21,643 shares0ShareOff exchangeISIN BE0003739530FSMA:ucb-68
780 shares0ShareOff exchangeISIN BE0003739530FSMA:ucb-26
3,823 shares0Options /warrants for employees or managersOff exchangeFSMA:ucb-46
2,787 shares0ShareOff exchangeISIN BE0003739530FSMA:ucb-131
2,787 shares0ShareOff exchangeISIN BE0003739530FSMA:ucb-132
2,787 shares0ShareOff exchangeISIN BE0003739530FSMA:ucb-133
11,542 shares0Options /warrants for employees or managersOff exchangeFSMA:ucb-116
3,084 shares0ShareOff exchangeISIN BE0003739530FSMA:ucb-225
2,464 shares0Options /warrants for employees or managersOff exchangeFSMA:ucb-190
2,787 shares0ShareOff exchangeISIN BE0003739530FSMA:ucb-178
3,873 shares0ShareOff exchangeISIN BE0003739530FSMA:ucb-108
3,489 shares0Options /warrants for employees or managersOff exchangeFSMA:ucb-76
5,802 shares0Options /warrants for employees or managersOff exchangeFSMA:ucb-24
4,043 shares0ShareOff exchangeISIN BE0003739530FSMA:ucb-1
3,528 shares0ShareOff exchangeISIN BE0003739530FSMA:ucb-60
2,549 shares0Options /warrants for employees or managersOff exchangeFSMA:ucb-18
3,873 shares0ShareOff exchangeISIN BE0003739530FSMA:ucb-90
3,000 shares@ €254.2710.6% of flowShareEuronext BrusselsISIN BE0003739530FSMA:ucb-198
25 of 56 declarations
About UCB
UCB is a Belgian biopharmaceutical company focused on developing medicines for severe diseases. It is listed on the Brussels stock market (XBRU).
